1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Estabrook Capital Management Buys GMAC Capital Trust I, SPDR S&P 500, Baker Hughes, Sells Medtronic PLC, CVS Health, PNC Financial Services Group

New York, NY, based Investment company Estabrook Capital Management buys GMAC Capital Trust I, SPDR S&P 500, Baker Hughes, The Mosaic Co, Deutsche Bank Contingent Capital Trust III, Kinder Morgan, NVIDIA, NXP Semiconductors NV, Brookfield Asset Management, AdvanSix, sells Medtronic PLC, CVS Health, PNC Financial Services Group, United Technologies, Amgen during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Estabrook Capital Management. As of 2016-12-31, Estabrook Capital Management owns 413 stocks with a total value of $637 million. These are the details of the buys and sells.

For the details of Estabrook Capital Management's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Estabrook+Capital+Management

These are the top 5 holdings of Estabrook Capital Management
  1. JPMorgan Chase & Co (JPM) - 370,706 shares, 5.02% of the total portfolio. Shares reduced by 12.46%
  2. Microsoft Corp (MSFT) - 473,631 shares, 4.62% of the total portfolio. Shares reduced by 8.92%
  3. General Electric Co (GE) - 812,194 shares, 4.03% of the total portfolio. Shares reduced by 8.36%
  4. Honeywell International Inc (HON) - 155,610 shares, 2.83% of the total portfolio. Shares reduced by 7.65%
  5. Intel Corp (INTC) - 497,394 shares, 2.83% of the total portfolio. Shares reduced by 10.9%
New Purchase: Brookfield Asset Management Inc (BAM)

Estabrook Capital Management initiated holdings in Brookfield Asset Management Inc. The purchase prices were between $32.54 and $36.09, with an estimated average price of $34.17. The stock is now traded at around $36.80. The impact to the portfolio due to this purchase was 0.01%. The holdings were 1,250 shares as of 2016-12-31.

New Purchase: NXP Semiconductors NV (NXPI)

Estabrook Capital Management initiated holdings in NXP Semiconductors NV. The purchase prices were between $96.59 and $104.49, with an estimated average price of $99.37. The stock is now traded at around $102.28. The impact to the portfolio due to this purchase was 0.01%. The holdings were 425 shares as of 2016-12-31.

New Purchase: AdvanSix Inc (ASIX)

Estabrook Capital Management initiated holdings in AdvanSix Inc. The purchase prices were between $14.01 and $22.97, with an estimated average price of $17.96. The stock is now traded at around $26.55. The impact to the portfolio due to this purchase was 0.01%. The holdings were 4,133 shares as of 2016-12-31.

New Purchase: CBS Corp (CBS)

Estabrook Capital Management initiated holdings in CBS Corp. The purchase prices were between $54.93 and $64.85, with an estimated average price of $59.32. The stock is now traded at around $65.33. The impact to the portfolio due to this purchase was 0.01%. The holdings were 938 shares as of 2016-12-31.

New Purchase: National Retail Properties Inc (NNNPRDCL)

Estabrook Capital Management initiated holdings in National Retail Properties Inc. The purchase prices were between $25.01 and $25.97, with an estimated average price of $25.38. The stock is now traded at around $25.29. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 97 shares as of 2016-12-31.

New Purchase: PS Business Parks Inc (PSBPRT)

Estabrook Capital Management initiated holdings in PS Business Parks Inc. The purchase prices were between $23.94 and $26.09, with an estimated average price of $24.97. The stock is now traded at around $25.27. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 163 shares as of 2016-12-31.

Added: GMAC Capital Trust I (ALLYPRA)

Estabrook Capital Management added to the holdings in GMAC Capital Trust I by 318.27%. The purchase prices were between $24.97 and $25.62, with an estimated average price of $25.32. The stock is now traded at around $25.74. The impact to the portfolio due to this purchase was 0.3%. The holdings were 101,325 shares as of 2016-12-31.

Added: SPDR S&P 500 (SPY)

Estabrook Capital Management added to the holdings in SPDR S&P 500 by 246.05%. The purchase prices were between $208.55 and $227.76, with an estimated average price of $218.6. The stock is now traded at around $233.70. The impact to the portfolio due to this purchase was 0.23%. The holdings were 9,326 shares as of 2016-12-31.

Added: Baker Hughes Inc (BHI)

Estabrook Capital Management added to the holdings in Baker Hughes Inc by 60.22%. The purchase prices were between $49.96 and $66.89, with an estimated average price of $59.37. The stock is now traded at around $61.50. The impact to the portfolio due to this purchase was 0.13%. The holdings were 32,881 shares as of 2016-12-31.

Added: The Mosaic Co (MOS)

Estabrook Capital Management added to the holdings in The Mosaic Co by 46492.00%. The purchase prices were between $22.83 and $31.42, with an estimated average price of $26.83. The stock is now traded at around $34.02. The impact to the portfolio due to this purchase was 0.11%. The holdings were 23,296 shares as of 2016-12-31.

Added: Deutsche Bank Contingent Capital Trust III (DTK)

Estabrook Capital Management added to the holdings in Deutsche Bank Contingent Capital Trust III by 619.09%. The purchase prices were between $23.5 and $25.29, with an estimated average price of $24.21. The stock is now traded at around $25.96. The impact to the portfolio due to this purchase was 0.08%. The holdings were 23,730 shares as of 2016-12-31.

Added: Kinder Morgan Inc (KMIPRA)

Estabrook Capital Management added to the holdings in Kinder Morgan Inc by 114.89%. The purchase prices were between $45.25 and $50.35, with an estimated average price of $48.32. The stock is now traded at around $49.60. The impact to the portfolio due to this purchase was 0.04%. The holdings were 10,100 shares as of 2016-12-31.

Sold Out: Teva Pharmaceutical Industries Ltd (TEVA)

Estabrook Capital Management sold out the holdings in Teva Pharmaceutical Industries Ltd. The sale prices were between $35.03 and $45.68, with an estimated average price of $39.93.

Sold Out: Roche Holding AG (RHHBY)

Estabrook Capital Management sold out the holdings in Roche Holding AG. The sale prices were between $27.08 and $30.96, with an estimated average price of $28.74.

Sold Out: C.R. Bard Inc (BCR)

Estabrook Capital Management sold out the holdings in C.R. Bard Inc. The sale prices were between $203.77 and $227.45, with an estimated average price of $217.29.

Sold Out: Merrill Lynch Capital Trust III (MERPRP)

Estabrook Capital Management sold out the holdings in Merrill Lynch Capital Trust III. The sale prices were between $25.37 and $26.73, with an estimated average price of $26.

Sold Out: Toyota Motor Corp (TM)

Estabrook Capital Management sold out the holdings in Toyota Motor Corp. The sale prices were between $110.56 and $123.07, with an estimated average price of $116.53.

Sold Out: Holly Energy Partners LP (HEP)

Estabrook Capital Management sold out the holdings in Holly Energy Partners LP. The sale prices were between $29.7 and $34.68, with an estimated average price of $32.46.

Reduced: Medtronic PLC (MDT)

Estabrook Capital Management reduced to the holdings in Medtronic PLC by 24.43%. The sale prices were between $71.23 and $86.39, with an estimated average price of $78.56. The stock is now traded at around $77.05. The impact to the portfolio due to this sale was -0.69%. Estabrook Capital Management still held 167,296 shares as of 2016-12-31.

Reduced: CVS Health Corp (CVS)

Estabrook Capital Management reduced to the holdings in CVS Health Corp by 83.46%. The sale prices were between $73.53 and $88.8, with an estimated average price of $80.91. The stock is now traded at around $78.67. The impact to the portfolio due to this sale was -0.63%. Estabrook Capital Management still held 9,497 shares as of 2016-12-31.



Here is the complete portfolio of Estabrook Capital Management. Also check out:

1. Estabrook Capital Management's Undervalued Stocks
2. Estabrook Capital Management's Top Growth Companies, and
3. Estabrook Capital Management's High Yield stocks
4. Stocks that Estabrook Capital Management keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


mtracy2Capital Screen
DBrizanall 2019Feb15
jranderson24Growth
ppapachristidisDividend NCAV
DANGORDONPE<14
pbarker46Owner earnings
haydarnehir20112-19%20nanocap
Nightdoc22-19 nanocap
DANGORDONREV GROWTH 4% 5YR 10% EARNINGS
merknt84div8
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK